German IT Stock News

Symrise AG ( ETR:SY1 ) is about to trade ex-dividend in the next 2 days. Typically, the ex-dividend date is two...

Earnings jump puts Berliner Effektengesellschaft in focus Berliner Effektengesellschaft (DB:BFV) has drawn fresh attention after reporting full year 2025 net income of €27.34 million, compared with €15.3 million for the prior year, pointing to higher profitability. See our latest analysis for Berliner Effektengesellschaft. Despite the stronger full year net income, recent share price momentum has been modest, with a 90 day share price return of 6.62% and a 1 year total shareholder return of...

Q1 2026 earnings event reshapes the picture for HELLA HELLA GmbH KGaA (XTRA:HLE) has become a focus for investors after Q1 2026 results showed €1.94b in sales, higher net income of €32.77m, and earnings per share of €0.29 from continuing operations. See our latest analysis for HELLA GmbH KGaA. The Q1 2026 update and reaffirmed guidance came as the share price touched €71.9, with a 7 day share price return of 4.96% but a 1 year total shareholder return decline of 17.49%, suggesting recent...

Wacker Neuson (XTRA:WAC) has come under fresh scrutiny after a sharp 20.59% share-price drop on the SIX exchange, raising questions about whether oversold conditions now offset ongoing concerns about profitability and operational strength. See our latest analysis for Wacker Neuson. The sharp 20.59% share price drop comes against a weaker backdrop, with a year-to-date share price return showing a 23.13% decline and a 1-year total shareholder return showing an 18.78% decline, indicating that...

As the European market navigates a complex landscape marked by stalled geopolitical negotiations and fluctuating oil prices, investors are keenly observing the corporate earnings season for signs of positive momentum. In this environment, companies with high insider ownership often attract attention as they can indicate strong internal confidence in future growth potential.

As European markets navigate a complex landscape marked by stalled geopolitical negotiations and fluctuating oil prices, the pan-European STOXX Europe 600 Index has remained relatively stable with modest gains. In this environment, dividend stocks can offer a degree of stability and income potential for investors seeking to balance risk amid economic uncertainties.

In late April 2026, Delivery Hero introduced Herogen, an in-house autonomous AI software delivery agent that can independently write, test, and propose production code, already handling over 100 code change requests per day and saving an estimated 250,000 hours of manual coding annually. By shifting developers’ work from writing code to directing AI through natural language, Herogen is repositioning engineering roles toward higher-level software architecture and potentially reshaping how...

Vossloh (XTRA:VOS) is back in focus after confirming its 2026 earnings guidance and securing new rail infrastructure contracts in Tanzania and Belgium, even as the latest quarter showed a net loss. See our latest analysis for Vossloh. Despite the recent quarterly loss, the confirmation of 2026 guidance and new rail contracts seems to be shifting sentiment. A 1 month share price return of 5.86% is helping to offset a 90 day share price decline of 9.54%, while the 5 year total shareholder...

With no specific news event setting the tone, Deutsche Telekom (XTRA:DTE) stock is drawing attention for its recent performance and current valuation metrics. This is prompting investors to reassess how it fits within a diversified portfolio. See our latest analysis for Deutsche Telekom. The recent 1 month share price return of 10.40% decline and 90 day share price return of 4.07% decline sit against a 1 year total shareholder return of 10.26% decline and a 5 year total shareholder return of...

How Sartorius Stock Has Been Performing Sartorius (XTRA:SRT3) has seen mixed share performance, with the stock roughly flat over the past week, modestly positive over the past month, but showing negative returns over the past 3 months, year to date, and the past year. Over a longer horizon, Sartorius also records negative total returns across the past 3 years and past 5 years. This provides a sense of how recent trading levels compare with earlier periods for the stock. See our latest...

Knorr-Bremse (XTRA:KBX) drew fresh attention after announcing a 9% dividend increase to €1.90 per share for fiscal 2025 and confirming several Supervisory Board changes, including the addition of digitalization expert Dr. Christian Schlögel. See our latest analysis for Knorr-Bremse. After the dividend announcement and Supervisory Board changes, the share price closed at €99.05. The 1-year total shareholder return of 12.56% compared with the 3-year total shareholder return of 63.72% suggests...

As the European markets navigate a complex landscape marked by stalled geopolitical negotiations and fluctuating oil prices, the pan-European STOXX Europe 600 Index remained steady with only slight gains. Amid this economic climate, identifying stocks that are priced below their estimated worth becomes crucial for investors seeking opportunities in value investing.

Nemetschek (XTRA:NEM) has drawn investor attention after reporting first quarter 2026 results, with double digit revenue and net income growth, a larger recurring revenue base, and the acquisition of Heavy Construction Systems Specialists. See our latest analysis for Nemetschek. Despite the strong first quarter update and the HCSS acquisition, Nemetschek’s share price has been under pressure, with a 90 day share price return of 19.64% and a year to date share price return of 31.56%. This has...

BASF (XTRA:BAS) is back in focus after its first quarter 2026 earnings, where sales reached €16,020 million and net income came in at €927 million, with earnings per share edging higher year on year. See our latest analysis for BASF. The share price has moved up to €54.74, with a 30 day share price return of 7.46% and a 90 day gain of 17.39%. The 1 year total shareholder return of 29.90% suggests momentum has been building over both shorter and longer periods as investors react to higher...

Deutsche Lufthansa (XTRA:LHA) is back in focus after a report highlighted sharply higher European jet fuel prices linked to Middle East conflict, with the airline responding through capacity cuts and relatively high 2026 fuel hedging. See our latest analysis for Deutsche Lufthansa. The stock has been volatile, with a 1 day share price return of 3.07% and a 90 day share price return showing a 17.86% decline. The 1 year total shareholder return of 18.91% indicates longer term gains despite...

Why Nordex Stock Is Back in Focus After Its Latest Update Nordex (XTRA:NDX1) has moved back onto investors’ radar after first quarter 2026 earnings showed higher net income and earnings per share, along with fresh progress on its Delta4000 turbine platform and tower certifications. See our latest analysis for Nordex. The latest product updates and first quarter 2026 earnings have coincided with a share price of €48.52 and strong momentum, with a 90 day share price return of 39.91% and a one...

AIXTRON (XTRA:AIXA) is back in focus after first quarter results showed sales of €59.38 million and a net loss of €21.94 million, while management highlighted strong optoelectronics orders linked to AI datacenter demand. See our latest analysis for AIXTRON. Despite the weak first quarter, AIXTRON's share price has surged recently, with a 30 day share price return of 41.17% and a 1 year total shareholder return of 267.80%. This suggests momentum has picked up as investors weigh AI linked order...

If you are wondering whether DWS Group GmbH KGaA is fairly priced right now, the key question is whether the current share price lines up with its underlying value. The stock last closed at €59.00, with returns of 3.5% over 7 days, 6.5% over 30 days, 4.6% year to date and 30.3% over 1 year, alongside a very large 3 year return and 135.5% over 5 years. Recent coverage has focused on DWS Group GmbH KGaA as an asset manager, which can affect how investors think about its fee resilience, cost...

Record 2025 results bring GEA Group (XTRA:G1A) into focus GEA Group (XTRA:G1A) is back on many investors’ radars after reporting a record 2025, highlighting 9.1% organic order intake growth, a proposed dividend of €1.30 per share, and detailed guidance for 2026. See our latest analysis for GEA Group. Despite record 2025 results, GEA Group’s share price has eased recently, with a 7 day share price return of 4.27% and a 30 day share price return of 6.11%. However, longer term total shareholder...

If you are wondering whether flatexDEGIRO's share price still offers value at current levels, the key question is how its market price compares with its underlying fundamentals. The stock recently closed at €30.48, with returns of 0.2% over 7 days, 1.4% over 30 days, a 16.0% decline year to date, and 29.2% over the last year. Together, these figures give mixed signals about how the market is pricing its prospects and risks. Recent coverage has focused on flatexDEGIRO's position within online...

Why Traton’s latest quarter is drawing fresh attention Traton (XTRA:8TRA) is back on investor radar after its first quarter update combined weaker headline earnings with an 18% jump in order intake and faster battery electric vehicle adoption. See our latest analysis for Traton. At a share price of €32.28, Traton has seen a 3.53% 1 day share price return and a 2.87% year to date share price return. Its 1 year total shareholder return of 16.44% and 3 year total shareholder return of 80.14%...

What the latest earnings and legal risks mean for Mercedes-Benz Group (XTRA:MBG) Mercedes-Benz Group (XTRA:MBG) has just paired softer first quarter 2026 results with an appeal against the UK Financial Conduct Authority’s car finance redress scheme, putting both earnings resilience and potential legal costs in focus for shareholders. For the quarter to March 31, 2026, the company reported sales of €25,497 million compared with €26,802 million a year earlier, and net income of €1,418 million...

Fresenius Medical Care (XTRA:FME) has amended its distribution agreement with Humacyte, Inc. regarding Symvess, an investigational acellular tissue engineered vessel. The revision realigns ex U.S. rights to Symvess and reshapes how the two companies coordinate on access to this advanced vascular product outside the United States. For you as an investor, this move sits at the intersection of medical technology and chronic kidney care, where XTRA:FME is a major global provider. Access to next...

While Clearway Energy, Inc. ( FRA:NY4B ) might not have the largest market cap around , it saw a significant share...